ClinConnect ClinConnect Logo
Search / Trial NCT06529185

Effect of Breather in COPD Patients with Intermittent Claudication

Launched by CAIRO UNIVERSITY · Jul 26, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a breathing device on patients with Chronic Obstructive Pulmonary Disease (COPD) who also experience intermittent claudication, which is leg pain that happens when walking due to poor blood flow. The goal is to see if using this device can help improve both breathing and blood flow in these patients. The trial is currently looking for male participants aged 45 to 55 who have been diagnosed with mild to moderate COPD and have a history of leg pain when walking. To qualify, participants should have a stable medical condition and a specific body weight range.

If you or someone you know fits this description, participating in this study could provide valuable insights into managing these conditions. Participants can expect to take part in exercises and tests that measure their breathing and blood flow while using the breathing device. It's important to note that individuals with certain heart or kidney issues, recent serious health problems, or those who may have difficulty following instructions won't be able to participate. This study aims to help improve the quality of life for patients dealing with both COPD and intermittent claudication.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
  • All patients will be clinically and medically stable when attending the study.
  • Body mass index (BMI) is 18.5 to 24.9 kg/m2.
  • History of unilateral exertional leg pain,
  • Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
  • And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.
  • Exclusion Criteria:
  • cardiovascular insufficiency,
  • Recent myocardial infarction,
  • heart failure,
  • arrhythmia,
  • DVT,
  • Intracranial hypertension,
  • Pneumonia,
  • kidney failure,
  • fractures,
  • uncooperative patients,
  • cognitive impairment preventing a patient from participation in exercises.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Dokki, , Egypt

Patients applied

0 patients applied

Trial Officials

Zahra M Serry, Assist.Prof

Study Director

Cairo University

MARWA M ELSAYED, Assist.Prof

Study Director

Cairo University

Amira I Almeldin, Assist.Prof

Study Director

Cairo University

reem M farahat, student

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported